Bulletin
Investor Alert

AbbVie Inc.

NYS: ABBV

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202428675/composite

$

94.28

Change

-0.01 -0.01%

Volume

Volume 251,739

Aug 4, 2020, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202428675/composite

Today's close

$ 95.94

$ 94.29

Change

-1.65 -1.72%

Day low

Day high

$94.06

$96.03

Open
Open: 95.92

52 week low

52 week high

$62.55

$101.28

Open

Market cap

$169.08B

Average volume

7.82M

P/E ratio

20.01

Rev. per Employee

$1.09M

EPS

4.71

Dividend

1.18

Div yield

5.01%

Ex dividend date

7/14/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/abbv

MarketWatch News on ABBV

  1. Buy Merck for Its Unappreciated Pipeline, Says Goldman

    10:47 a.m. Aug. 3, 2020

    - Bill Alpert

  2. AbbVie Beats Earnings Expectations but Stock Falls Anyway

    10:26 a.m. July 31, 2020

    - Josh Nathan-Kazis

  3. AbbVie shares up 1.7% premarket

    7:49 a.m. July 31, 2020

    - Ciara Linnane

  4. AbbVie Q2 revenue $10.425 bln vs. $8.255 bln; FactSet consensus $9.939 bln

    7:48 a.m. July 31, 2020

    - Ciara Linnane

  5. AbbVie Q2 adj. loss per share $2.34; FactSet consensus $2.20

    7:47 a.m. July 31, 2020

    - Ciara Linnane

  6. AbbVie Q2 loss per share 46 cents vs. EPS 49 cents

    7:46 a.m. July 31, 2020

    - Ciara Linnane

  7. How gene therapy and CRISPR are helping to cure blindness

    8:21 a.m. June 26, 2020

    - Hemant Khanna

  8. A Yes Vote for AMD Stock

    7:00 p.m. June 19, 2020

  9. AbbVie Stock Has More Upside, Analyst Says

    12:08 p.m. June 19, 2020

    - Bill Alpert

  10. Recent Dividend Moves Have Been Mixed as Virus Continues to Cloud Picture

    12:05 p.m. June 19, 2020

    - Lawrence C. Strauss

  11. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/abbv

Other News on ABBV

  1. 3 Diverse Large-Cap Stocks to Buy Now to Boost Your Long-Term Portfolio

    7:44 p.m. Today

    - Zacks.com

  2. Keytruda Powers a Stellar Q2 for Merck

    12:44 p.m. Today

    - InvestorPlace.com

  3. 10-Q: ABBVIE INC.

    9:58 a.m. Today

    - Edgar Online - (EDG = 10Q, 10K)

  4. Ingrezza Remains Surprisingly Strong For Neurocrine

    8:39 a.m. Today

    - Seeking Alpha

  5. ImmunoGen (IMGN) Q2 Earnings and Sales Beat, Shares Down

    10:53 a.m. Aug. 3, 2020

    - Zacks.com

  6. Nasdaq Indexes Lead Way on Both Sides of Atlantic

    5:30 a.m. Aug. 3, 2020

    - Ben Dummett

  7. Merck: Potential Biden Win Worrisome

    12:03 a.m. Aug. 3, 2020

    - Seeking Alpha

  8. The Market Continues to Undervalue AbbVie

    2:31 p.m. Aug. 2, 2020

    - GuruFocus.com

  9. Gilead: Perhaps A Value Trap No Longer

    11:20 a.m. Aug. 2, 2020

    - Seeking Alpha

  10. How To Retire With $1.5 Million Starting At 40

    9:43 a.m. Aug. 1, 2020

    - Seeking Alpha

  11. AbbVie's (ABBV) Q2 Earnings and Revenues Beat Estimates

    1:09 p.m. July 31, 2020

    - Zacks.com

  12. AbbVie Earnings: ABBV Stock Drops 2% Despite Q2 Beats

    11:10 a.m. July 31, 2020

    - InvestorPlace.com

  13. Earnings & Economic Data Deluge

    10:19 a.m. July 31, 2020

    - Zacks.com

  14. AbbVie (ABBV) Q2 Earnings and Revenues Beat Estimates

    9:05 a.m. July 31, 2020

    - Zacks.com

  15. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/abbv

Press Releases on ABBV

  1. Yearly US Gainers With Bullish Signs: $ABBV $KHC $ORCL

    10:45 a.m. Today

    - The Market Signal

  2. AbbVie Reports Second-Quarter 2020 Financial Results

    9:36 a.m. Aug. 3, 2020

    - PR Newswire - PRF

  3. Inhalation Anesthesia Market is expected to see growth rate of 4.13%

    5:26 a.m. July 31, 2020

    - Market Insight Reports

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.